ConductScience.org, home

Paper36992155

Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics.

Li Z and 4 others. Vaccines (Basel), 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics. Papers, record 36992155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36992155

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2023
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2023-04-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li ZZijiehttps://orcid.org/0000-0002-1860-1029
2Ji WWangquan
3Chen SShuaiyinhttps://orcid.org/0000-0001-6129-0310
4Duan GGuangcai
5Jin YYuefeihttps://orcid.org/0000-0002-1523-0808

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82273695, 82002147, 82073618National Natural Science Foundation of ChinaPubMed
2019M662543China Postdoctoral Science FoundationPubMed
21A310026Key Scientific Research Project of Henan Institution of Higher EducationPubMed

Source PubMed

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119414569Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19414569PubMed
232619885Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.Eur J Med Chem2020https://conductscience.org/library/papers/32619885PubMed
325212137Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins.Food Chem2011https://conductscience.org/library/papers/25212137PubMed
432963221IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex.Nat Commun2020https://conductscience.org/library/papers/32963221PubMed
524971492Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway.Antiviral Res2014https://conductscience.org/library/papers/24971492PubMed
632075935The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses.J Virol2020https://conductscience.org/library/papers/32075935PubMed
710471549Activity of pleconaril against enteroviruses.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10471549PubMed
831924205Cellular receptors for enterovirus A71.J Biomed Sci2020https://conductscience.org/library/papers/31924205PubMed
928351508Regulation of enterovirus 2A protease-associated viral IRES activities by the cell's ERK signaling cascade: Implicating ERK as an efficiently antiviral target.Antiviral Res2017https://conductscience.org/library/papers/28351508PubMed
1010500114Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10500114PubMed
1131071193Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.PLoS Pathog2019https://conductscience.org/library/papers/31071193PubMed
1228835799Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.ACS Med Chem Lett2017https://conductscience.org/library/papers/28835799PubMed
1331167919In Vitro and In Vivo Inhibition of the Infectivity of Human Enterovirus 71 by a Sulfonated Food Azo Dye, Brilliant Black BN.J Virol2019https://conductscience.org/library/papers/31167919PubMed
1435847514Enterovirus A71 antivirals: Past, present, and future.Acta Pharm Sin B2022https://conductscience.org/library/papers/35847514PubMed
1527875780VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction.Virology2017https://conductscience.org/library/papers/27875780PubMed
1623509286Structure of human enterovirus 71 in complex with a capsid-binding inhibitor.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23509286PubMed
1712110211Picornavirus-receptor interactions.Trends Microbiol2002https://conductscience.org/library/papers/12110211PubMed
18347874434-Iminooxazolidin-2-One as a Bioisostere of Cyanohydrin Suppresses EV71 Proliferation by Targeting 3Cpro.Microbiol Spectr2021https://conductscience.org/library/papers/34787443PubMed
1924509833More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules.Nat Struct Mol Biol2014https://conductscience.org/library/papers/24509833PubMed
2022563456Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.PLoS One2012https://conductscience.org/library/papers/22563456PubMed

See all 64 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41598328Cutaneous-Tropism Viruses: Unraveling Pathogenetic Mechanisms and Immunoprophylactic Strategies.Life (Basel)2026https://conductscience.org/library/papers/41598328PubMed
41481672Spatial heterogeneity in the temperature-hand, foot, and mouth disease association among children: A multicounty time-series study in western China.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/41481672PubMed
40662060Enhancing Clinical Nursing Guidance and Optimizing Care Processes for Improved Hand-Foot-and-Mouth Disease Treatment Outcomes.J Multidiscip Healthc2025https://conductscience.org/library/papers/40662060PubMed
39788784Childhood hand, foot and mouth disease sequelae cohort study in Henan, China: cohort profile.BMJ Open2025https://conductscience.org/library/papers/39788784PubMed
39075371Single nucleotide polymorphism of Notch1 gene rs3124599 allele is associated with the severity of CVA6-related HFMD in the Chinese Han population.BMC Infect Dis2024https://conductscience.org/library/papers/39075371PubMed
38441464Construction of an infectious clone for enterovirus A89 and mutagenesis analysis of viral infection and cell binding.Microbiol Spectr2024https://conductscience.org/library/papers/38441464PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36992155

GET https://conductscience.org/api/papers/v1/36992155/references?page=2